| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 33792 |
| 1 | PREDNISONE | 19662 |
| 2 | METHOTREXATE SODIUM | 15617 |
| 3 | ETANERCEPT | 14200 |
| 4 | METHOTREXATE | 14187 |
| 5 | INFLIXIMAB | 13990 |
| 6 | ACETAMINOPHEN | 11224 |
| 7 | RITUXIMAB | 10296 |
| 8 | ERGOCALCIFEROL | 10081 |
| 9 | GABAPENTIN | 9459 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IVOSIDENIB | 495 | 0.5061 |
| 1 | INFLIXIMAB-DYYB | 3944 | 0.4463 |
| 2 | RITUXIMAB-ABBS | 510 | 0.3744 |
| 3 | ISAVUCONAZONIUM SULFATE | 607 | 0.3467 |
| 4 | BECAPLERMIN | 671 | 0.3195 |
| 5 | PURIXAN | 165 | 0.3137 |
| 6 | DEFIBROTIDE SODIUM | 490 | 0.2608 |
| 7 | BOTULINUM TOXIN TYPE A | 1278 | 0.2497 |
| 8 | ANAKINRA | 2340 | 0.2491 |
| 9 | IBUPROFEN AND FAMOTIDINE | 320 | 0.2435 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 44315 |
| 1 | RANK Ligand Inhibitor [EPC] | 33792 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 32905 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 24878 |
| 4 | Atypical Antipsychotic [EPC] | 17677 |
| 5 | Kinase Inhibitor [EPC] | 17272 |
| 6 | Benzodiazepine [EPC] | 16165 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 14502 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 14153 |
| 9 | Anti-epileptic Agent [EPC] | 13913 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Recombinant Antithrombin [EPC] | 7 | 0.4375 |
| 1 | Human Platelet-derived Growth Factor [EPC] | 671 | 0.3195 |
| 2 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 120 | 0.3023 |
| 3 | Antileishmanial [EPC] | 57 | 0.2984 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 2340 | 0.2491 |
| 5 | RANK Ligand Inhibitor [EPC] | 33792 | 0.2207 |
| 6 | Lipoglycopeptide Antibacterial [EPC] | 150 | 0.2161 |
| 7 | Interferon gamma Blocker [EPC] | 8 | 0.2051 |
| 8 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 160 | 0.2041 |
| 9 | Lead Chelator [EPC] | 9 | 0.2000 |